Clinical Trials Browser

Phase 2/3 × Unknown × Radiofrequency Ablation × Clear all

NCT03686254 2018-09-26

The Effects of RFA in Combination With Second-line Chemotherapy and Bevacizumab on Unresectable CRLM

Phase 2/3 Unknown

Gastrointestinal

Colonic Neoplasms